Company Overview and News

0
Orion Minerals continues to progress drilling at Prieska Zinc-Copper Project

2018-07-16 proactiveinvestors.com.au
Orion Minerals Ltd (ASX:ORN) is continuing to progress its resource drill-out program at the Prieska Zinc-Copper Project in South Africa.
ORN

0
Orion Minerals raising $11 million for Prieska Zinc-Copper Project

2018-06-25 proactiveinvestors.com.au
Orion Minerals Ltd (ASX:ORN) will use $11 million in placement funds to advance a bankable feasibility study (BFS) on the Prieska Zinc-Copper Project in South Africa.
ORN

0
Orion Minerals sees 'exceptional opportunity' in Areachap Belt exploration

2018-05-29 proactiveinvestors.com.au
Orion Minerals Limited (ASX:ORN) (JSE:ORN) CEO and managing director Errol Smart speaks to Proactive Investors about the exploration and development company's portfolio of projects in Australia and South Africa.
ORN IGO IIDDY

0
Orion Minerals says exploration activities in South Africa highlights “very encouraging” high potential for mineralisation

2018-05-29 proactiveinvestors.com.au
Orion Minerals Limited (ASX:ORN) (JSE:ORN) has said its regional exploration activities in the Areachap Belt, South Africa, where it holds prospecting rights over 196,760 hectares has highlighted “very encouraging” high potential for mineralisation.
ORN

0
Orion Minerals secures $5 million from Independence Group for base metal development strategy

2018-05-18 proactiveinvestors.com.au
Orion Minerals Ltd (ASX:ORN, JSE:ORN) has entered into an agreement with leading mid-tier miner, Independence Group NL (ASX:IGO), for IGO to subscribe for $5 million worth of shares in Orion.
ORN IGO IIDDY

0
Orion Minerals has nearly 30mln tonnes of zinc ore in South Africa, and significant private equity support

2018-04-26 proactiveinvestors.com.au
“The Prieska project was discovered by Anglovaal in 1968,” says Errol Smart, chief executive of Orion Minerals Ltd (ASX:ORN).
ORN

0
Orion Minerals upgrades world-class zinc-copper deposit in South Africa

2018-04-09 proactiveinvestors.com.au
Orion Minerals Ltd (ASX:ORN) has established a maiden resource of 5.2 million tonnes containing 253,000 tonnes zinc and 67,000 tonnes copper for the Vardocube area within the Prieska project in South Africa.
ORN

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:ORN / ORION GOLD NL on message board site Silicon Investor.

Ornithology Car Nut Corner: All About Cars
Tuesday Morning Expat Corner
A Poetry Corner Akorn Inc.
Corning Incorporated (GLW) Hurricanes, Tornadoes and Other Natural Disasters
KERMu0027S KORNER Daily Story Corner